Published in J Biol Chem on December 15, 1985
Identification of de novo synthesized and relatively older proteins: accelerated oxidative damage to de novo synthesized apolipoprotein A-1 in type 1 diabetes. Diabetes (2010) 0.96
Macrophage metalloproteinases degrade high-density-lipoprotein-associated apolipoprotein A-I at both the N- and C-termini. Biochem J (2002) 0.83
Identification of sites in apolipoprotein A-I susceptible to chymase and carboxypeptidase A digestion. Biosci Rep (2012) 0.78
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med (2001) 7.51
Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation (1997) 4.41
A molecular theory of lipid-protein interactions in the plasma lipoproteins. FEBS Lett (1974) 3.43
Postoperative analgesia for shoulder surgery: a critical appraisal and review of current techniques. Anaesthesia (2010) 3.25
Isolation of subgenus B adenovirus during a fatal outbreak of enterovirus 71-associated hand, foot, and mouth disease in Sibu, Sarawak. Lancet (1999) 3.21
Serum cholesterol. Doing the right thing. Circulation (1993) 3.16
Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb (1992) 2.31
Digital imaging fluorescence microscopy: spatial heterogeneity of photobleaching rate constants in individual cells. J Cell Biol (1985) 2.20
Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation (1986) 2.06
Lipoprotein structure and metabolism. Physiol Rev (1976) 2.04
Multicentre survey of radiologically inserted gastrostomy feeding tube (RIG) in the UK. Clin Radiol (2012) 2.04
Variation in volatile organic compounds in the breath of normal humans. J Chromatogr B Biomed Sci Appl (1999) 1.91
Familial apolipoprotein E deficiency. J Clin Invest (1986) 1.87
Type III hyperlipoproteinemia associated with apolipoprotein E deficiency. Science (1981) 1.84
A set of endoplasmic reticulum proteins possessing properties of molecular chaperones includes Ca(2+)-binding proteins and members of the thioredoxin superfamily. J Biol Chem (1994) 1.83
Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholine. Biochemistry (1973) 1.81
Successful delivery in a morbidly obese patient after failed intubation and regional technique. Br J Anaesth (2007) 1.81
Lipoproteins: structure and function. Annu Rev Biochem (1975) 1.76
Butyrate and glucose metabolism by colonocytes in experimental colitis in mice. Gut (2000) 1.75
Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circ Res (2001) 1.74
Relation of diet to high-density-lipoprotein cholesterol in middle-aged marathon runners, joggers, and inactive men. N Engl J Med (1980) 1.72
Introduction to the plasma lipoproteins. Methods Enzymol (1986) 1.71
Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein A-I. J Clin Invest (1978) 1.69
Human plasma lipoprotein [a]. Structural properties. J Biol Chem (1983) 1.68
Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase. Biochemistry (1975) 1.66
Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb (1993) 1.65
Accuracy and precision of analyses for total cholesterol as measured with the Reflotron cholesterol method. Clin Chem (1989) 1.60
Effects of donepezil on cortical activation in mild cognitive impairment: a pilot double-blind placebo-controlled trial using functional MR imaging. AJNR Am J Neuroradiol (2008) 1.59
Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. J Lipid Res (2000) 1.57
Community based trials and informed consent in rural north India. J Med Ethics (2004) 1.56
The plasma lipoproteins: structure and metabolism. Annu Rev Biochem (1978) 1.54
Health family trees: a tool for finding and helping young family members of coronary and cancer prone pedigrees in Texas and Utah. Am J Public Health (1988) 1.53
Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro. Proc Natl Acad Sci U S A (1978) 1.53
AHA consensus panel statement. Preventing heart attack and death in patients with coronary disease. The Secondary Prevention Panel. J Am Coll Cardiol (1995) 1.52
Partner violence and sexual HIV-risk behaviors among women in an inner-city emergency department. Violence Vict (1998) 1.51
The primary structure of human apolipoprotein A-IV. Biochim Biophys Acta (1989) 1.50
The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol (2000) 1.46
Human pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusers. J Psychopharmacol (2008) 1.45
Plasma lipid and lipoprotein response of humans to beef fat, coconut oil and safflower oil. Am J Clin Nutr (1985) 1.45
Oncogenic Ras sensitizes cells to apoptosis by Par-4. J Biol Chem (1999) 1.45
The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus. Epidemiol Infect (2007) 1.43
Risk reduction. Circulation (2000) 1.42
A prospective study of genetic markers of susceptibility to infection and inflammation, and the severity, progression, and regression of coronary atherosclerosis and its response to therapy. J Mol Med (Berl) (2000) 1.42
Communication patterns in a biomedical research center. J Med Educ (1978) 1.42
An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reduction. Am J Cardiol (1991) 1.42
Kinetics of lipid--protein interactions: interaction of apolipoprotein A-I from human plasma high density lipoproteins with phosphatidylcholines. Biochemistry (1978) 1.41
Effects of cyclosporine therapy on plasma lipoprotein levels. JAMA (1989) 1.40
On the protein defect in abetalipoproteinemia. N Engl J Med (1971) 1.40
Halotolerance of Methanobacterium thermoautotrophicum delta H and Marburg. J Bacteriol (1994) 1.39
The cyanogen bromide peptides of the apoprotein of low density lipoprotein (ApoB): its molecular weight from a chemical view. Biochem Biophys Res Commun (1978) 1.39
The complete cDNA and amino acid sequence of human apolipoprotein B-100. J Biol Chem (1986) 1.39
Decreased expression of the pro-apoptotic protein Par-4 in renal cell carcinoma. Oncogene (1999) 1.38
Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. Proc Natl Acad Sci U S A (1983) 1.36
Preventing heart attack and death in patients with coronary disease. Circulation (1995) 1.36
The human apolipoprotein B-100 gene: a highly polymorphic gene that maps to the short arm of chromosome 2. Biochem Biophys Res Commun (1985) 1.36
Molecular cloning and expression of partial cDNAs and deduced amino acid sequence of a carboxyl-terminal fragment of human apolipoprotein B-100. Proc Natl Acad Sci U S A (1985) 1.35
Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II. Proc Natl Acad Sci U S A (1977) 1.35
Effects of saturated and polyunsaturated fat diets on the chemical composition and metabolism of low density lipoproteins in man. J Lipid Res (1980) 1.30
Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA. Eur J Immunol (1993) 1.29
Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects. J Clin Invest (1984) 1.29
Three-dimensional structure of low density lipoproteins by electron cryomicroscopy. Proc Natl Acad Sci U S A (1999) 1.29
Towards mainstreaming of biodiversity data publishing: recommendations of the GBIF Data Publishing Framework Task Group. BMC Bioinformatics (2011) 1.28
The structure of the human apolipoprotein C-II gene. Electron microscopic analysis of RNA:DNA hybrids, complete nucleotide sequence, and identification of 5' homologous sequences among apolipoprotein genes. J Biol Chem (1985) 1.28
Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages. J Clin Invest (1982) 1.27
A comparative study on the removal of cellular lipids from Landschütz ascites cells by human plasma apolipoproteins. J Biol Chem (1975) 1.27
A member of a family of sulfate-activating enzymes causes murine brachymorphism. Proc Natl Acad Sci U S A (1998) 1.26
Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B. Arteriosclerosis (1985) 1.25
Comparisons for body mass index and body fat percent among Puerto Ricans, blacks, whites and Asians living in the New York City area. Obes Res (1996) 1.25
Structure of apolipoprotein B-100 of human low density lipoproteins. Arteriosclerosis (1989) 1.24
Lipid-protein interactions in the plasma lipoproteins. Biochim Biophys Acta (1977) 1.23
Reconstituted low density lipoprotein: a vehicle for the delivery of hydrophobic fluorescent probes to cells. J Supramol Struct (1979) 1.23
Limitations of behavioral treatment of obesity: review and analysis. J Behav Med (1981) 1.23
Kinetics of lipid--protein interactions: effect of cholesterol on the association of human plasma high-density apolipoprotein A-I with L-alpha-dimyristoylphosphatidylcholine. Biochemistry (1979) 1.23
The primary structure of human plasma high density apolipoprotein glutamine I (ApoA-I). II. The amino acid sequence and alignment of cyanogen bromide fragments IV, III, and I. J Biol Chem (1975) 1.22
Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): efficacy and tolerability of long-term treatment with lovastatin in women. J Womens Health Gend Based Med (2001) 1.22
Low-density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during conversion of hypertriglyceridemic very-low-density lipoprotein to low-density lipoproteins. J Biol Chem (1984) 1.22
Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia. J Clin Invest (1982) 1.20
Nontoxigenic Vibrio cholerae 01 serotype Inaba biotype El Tor associated with a cluster of cases of cholera in southern India. J Clin Microbiol (1996) 1.20
Annexin II: a mediator of the plasmin/plasminogen activator system. Trends Cardiovasc Med (1999) 1.19
The effect of carbohydrate on the structure and stability of erythropoietin. J Biol Chem (1991) 1.18
Apolipoprotein E mediates uptake of Sf 100-400 hypertriglyceridemic very low density lipoproteins by the low density lipoprotein receptor pathway in normal human fibroblasts. J Biol Chem (1983) 1.17
Deletion and site-directed mutagenesis of the ATP-binding motif (P-loop) in the bifunctional murine ATP-sulfurylase/adenosine 5'-phosphosulfate kinase enzyme. J Biol Chem (1998) 1.17
Primary structure of very low density apolipoprotein C-II of human plasma. Proc Natl Acad Sci U S A (1977) 1.16
Production, biological activity, and structure of recombinant basic fibroblast growth factor and an analog with cysteine replaced by serine. J Biol Chem (1988) 1.16
Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation (1996) 1.16
Evaluation of genetic diversity among Pseudomonas citronellolis strains isolated from oily sludge-contaminated sites. Appl Environ Microbiol (2003) 1.15
Measurement and prediction of the rates of spontaneous transfer of phospholipids between plasma lipoproteins. Biochim Biophys Acta (1984) 1.15
Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins. Atherosclerosis (1999) 1.14
Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase. J Clin Invest (1984) 1.14
Comparison of 2-year weight loss trends in behavioral treatments of obesity: diet, exercise, and combination interventions. J Am Diet Assoc (1996) 1.14
Blood cholesterol screening in several environments using a portable, dry-chemistry analyzer and fingerstick blood samples. Lipid Research Clinics Cholesterol Screening Study Group. Am J Cardiol (1990) 1.13
Evidence for the identity of the major apoprotein in low density and very low density lipoproteins in normal subjects and patients with familial hyperlipoproteinemia. J Clin Invest (1972) 1.13
Apolipoprotein EBethesda: a new variant of apolipoprotein E associated with type III hyperlipoproteinemia. J Clin Endocrinol Metab (1983) 1.13
Interactions of the major risk factors for coronary heart disease. Am J Med (1986) 1.12
Studies on the protein defect in Tangier disease. Isolation and characterization of an abnormal high density lipoprotein. J Clin Invest (1972) 1.12